Literature DB >> 28950987

Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway.

M L Mora-García1, L R Ávila-Ibarra2, R García-Rocha3, B Weiss-Steider4, J Hernández-Montes5, C A Don-López6, V Gutiérrez-Serrano7, I J Titla-Vilchis8, M C Fuentes-Castañeda9, A Monroy-Mora10, L F Jave-Suárez11, R Chacón-Salinas12, L Vallejo-Castillo13, S M Pérez-Tapia14, A Monroy-García15.   

Abstract

BACKGROUND: The expression of CD73 in tumor cells plays a significant role in the production of adenosine (Ado) that suppresses antitumor effector cells.
METHODS: In this study we analyzed the capability of HPV-positive (HPV+) cervical cancer (CeCa) cell lines CaSki, SiHa, HeLa, and RoVa; and HPV-negative (HPV-) cell lines C33A and ViBo to produce Ado and inhibit effector functions of CD8+ T cells.
RESULTS: HPV+ CeCa cells expressed significantly higher levels of CD73 in the membrane (p<0.01) than HPV- CeCa cells and this expression was associated with the production of larger amounts of Ado (>400μM) compared to HPV-CeCa cells (<200μM) in the presence of AMP, as well asa stronger inhibition of (>50%) proliferation, activation, and cytotoxic activity of CD8+ T cells via interaction with A2A adenosine receptor. We also provide evidence that silenced E6/E7 expression in CeCa cells, strongly reduced its CD73 expression level and its capability to generate Ado.
CONCLUSION: This results suggest that HPV infection, which is associated with more than 99% of CeCa cases, may present an increased constitutive expression of CD73 in cervical neoplasia to contribute to the suppression of the immune response mediated by the production of large amounts of Ado.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenosine; CD73; CTLs; Cervical cancer cells; Immunosuppression

Mesh:

Substances:

Year:  2017        PMID: 28950987     DOI: 10.1016/j.cellimm.2017.09.002

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  6 in total

1.  Decreased local immune response and retained HPV gene expression during chemoradiotherapy are associated with treatment resistance and death from cervical cancer.

Authors:  Pippa F Cosper; Christopher McNair; Iván González; Nathan Wong; Karen E Knudsen; Jason J Chen; Stephanie Markovina; Julie K Schwarz; Perry W Grigsby; Xiaowei Wang
Journal:  Int J Cancer       Date:  2019-12-04       Impact factor: 7.396

Review 2.  Purinergic signaling and tumor microenvironment in cervical Cancer.

Authors:  Marta Schmidt Pfaffenzeller; Maria Luiza Mukai Franciosi; Andréia Machado Cardoso
Journal:  Purinergic Signal       Date:  2020-03-13       Impact factor: 3.765

3.  Cervical Cancer Cells Express Markers Associated with Immunosurveillance.

Authors:  Adriana Gutiérrez-Hoya; Octavio Zerecero-Carreón; Arturo Valle-Mendiola; Martha Moreno-Lafont; Rubén López-Santiago; Benny Weiss-Steider; Isabel Soto-Cruz
Journal:  J Immunol Res       Date:  2019-05-06       Impact factor: 4.818

4.  Adenosine Generated by Regulatory T Cells Induces CD8+ T Cell Exhaustion in Gastric Cancer through A2aR Pathway.

Authors:  Linsen Shi; Min Feng; Shangce Du; Xu Wei; Hu Song; Xu Yixin; Jun Song; Guan Wenxian
Journal:  Biomed Res Int       Date:  2019-12-14       Impact factor: 3.411

5.  Detection of CD39 and a Highly Glycosylated Isoform of Soluble CD73 in the Plasma of Patients with Cervical Cancer: Correlation with Disease Progression.

Authors:  Ricardo Muñóz-Godínez; María de Lourdes Mora-García; Benny Weiss-Steider; Juan José Montesinos-Montesinos; Adriana Del Carmen Aguilar-Lemarroy; Rosario García-Rocha; Jorge Hernández-Montes; Christian Azucena Don-López; Luis Roberto Ávila-Ibarra; Daniela Berenice Torres-Pineda; Gabriela Molina-Castillo; Rommel Chacón-Salinas; Luis Vallejo-Castillo; Sonia Mayra Pérez-Tapia; Alberto Monroy-García
Journal:  Mediators Inflamm       Date:  2020-12-07       Impact factor: 4.711

6.  Cancer Biology, Epidemiology, and Treatment in the 21st Century: Current Status and Future Challenges From a Biomedical Perspective.

Authors:  Patricia Piña-Sánchez; Antonieta Chávez-González; Martha Ruiz-Tachiquín; Eduardo Vadillo; Alberto Monroy-García; Juan José Montesinos; Rocío Grajales; Marcos Gutiérrez de la Barrera; Hector Mayani
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.